After four years of following patients taking Wegovy, the trial revealed how quickly it worked, if patients kept the weight off -- and something else surprising.
Researchers at the European Congress of Obesity released results of a new clinical trial of Wegovy, the weight loss version of Ozempic .drugs can help with heart failure and heart attack. This week at the European Congress of Obesity, researchers released the overall results of the longest clinical trial yet of the drug Wegovy, the weight loss version of Ozempic .
"These medications may have an effect on inflammation, and chronic inflammation can contribute to a lot of health issues," he said. But for shedding pounds, the results show the average body weight reduction of about 10% continued for a year and was more or less sustained for up to four years. As far as safety, there are no surprises. Serious side effects such as gastroparesis were rare. The more common nausea, diarrhea and constipation were reasons why some people stopped taking it. The steep out-of-pocket costs even with insurance are another reason.Ali said people should remember that Wegovy and other similar weight loss drugs are not magic potions - you still have to do the work.
Weight Loss Ozempic Clinical Trial Study Side Effects 14816519
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sanders Releases New Report, PBMs Welcome Lower List Prices for Ozempic and WegovyNewswire Editor is a Common Dreams staff position.
Read more »
Wegovy Could Prevent 34,000 Strokes and Heart Attacks Annually in the USNew research by Dandelion Health using medical records and AI suggests that Wegovy, a weight loss drug, can prevent 34,000 strokes and heart attacks annually in the United States. The findings suggest potential benefits for a wider group of people, including those without prior cardiovascular incidents.
Read more »
The maker of Wegovy and Ozempic will testify about the price of the drugsLawmakers are set to scrutinize the high cost of weight loss and diabetes drugs, which depending upon your insurance can range from $0 a month to over $1,000 if it isn't covered.
Read more »
Ozempic, Wegovy maker Novo Nordisk faces hearing over high cost of weight loss drugsBlockbuster drugs Ozempic and Wegovy have sparked conversation and changed weight loss worldwide. In an exclusive interview, NBC News’ Megan Fitzgerald sits down with Novo Nordisk CEO Lars Fruergaard Jørgensen who helmed it all, and presses him on the high price, drug shortages, and long-term effects.
Read more »
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugsIs Novo Nordisk helping Americans save taxpayer money or ripping them off? The company's CEO is scheduled to testify Tuesday on Capitol Hill.
Read more »
Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations nextNovo Nordisk’s weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an antitrust suit against Epic…
Read more »